Current Affairs

Niraparib Shows Mixed Signals in Early Prostate Cancer Treatment

(MedPage Today)-At the annual meeting of the recent American Urology Association, data about Nairarab (Zaigola) was presented in the treatment of treatment, and the repair of DNA damage (DDR)-translated prostate cancer that suffers from a deficiency in this, but also raised important questions …

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button